Loading clinical trials...
Loading clinical trials...
Systemic Allergic Reactions to SARS-CoV-2 Vaccination
Conditions
Interventions
Moderna COVID-19 Vaccine
Pfizer-BioNTech COVID-19 Vaccine
+1 more
Locations
29
United States
University of Arizona Health Sciences, College of Medicine Tucson, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine
Tucson, Arizona, United States
Arkansas Children's, University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
University of California, Los Angeles Medical Center
Los Angeles, California, United States
Stanford Medicine, Sean N. Parker Center for Allergy & Asthma Research
Stanford, California, United States
National Jewish Health
Denver, Colorado, United States
University Health, University of Miami Health System
Miami, Florida, United States
Start Date
April 7, 2021
Primary Completion Date
April 20, 2022
Completion Date
April 27, 2022
Last Updated
August 12, 2025
NCT06631287
NCT04565665
NCT04978571
NCT07221162
NCT06082518
NCT06679140
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions